Accel Wealth Management Recursion Pharmaceuticals, Inc. Transaction History
Accel Wealth Management
- $268 Million
- Q1 2025
A detailed history of Accel Wealth Management transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Accel Wealth Management holds 44,050 shares of RXRX stock, worth $209,678. This represents 0.1% of its overall portfolio holdings.
Number of Shares
44,050
Previous 45,800
3.82%
Holding current value
$209,678
Previous $309,000
17.48%
% of portfolio
0.1%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
355Shares Held
287MCall Options Held
2.83MPut Options Held
3.64M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$166 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA34MShares$162 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$116 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$82.4 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$69.8 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $859M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...